Botanical species · safety record

Astragalus mongholicus

The EFSA Compendium of Botanicals holds 4 constituent measurements and 2 genotoxicity assays for Astragalus mongholicus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Astragalus mongholicus Bunge

4Constituent measurements
2Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Saponins2
  • Calycosin1
  • Formononetin1

Plant parts

  • Unspecified3
  • Roots and other underground parts1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
CalycosinUnspecifiedUnspecifiedNo resolvable identifier
FormononetinUnspecifiedUnspecifiedNo resolvable identifier
SaponinsRoots and other underground partsUnspecifiedNo resolvable identifier
SaponinsUnspecifiedUnspecifiedNo resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Positivegene mutationbacterial reverse mutation assaySalmonella typhimurium (as organism)WithNo resolvable identifier
PositiveDNA damage and/or repairmicronucleus assayHouse mouse (as animal)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. YIN, XJ., LIU, DX., WANG, HC., ZHOU, Y. A STUDY ON THE MUTAGENICITY OF 102 RAW PHARMACEUTICALS USED IN CHINESE TRADITIONAL MEDICINE. MUTATION RESEARCH, 1991, vol. 260, no. 1, p. 73-82.
  2. Ionkova, I., Kartnig, T. Densitometric determination of cycloartane triterpene saponins from transformed root cultures of Astragalus mongholicus Bge. . Pharmazie, 1997, vol. 52, no. 3, p. 218-220.
  3. Xie, Wei., Lu, Yili., Yang, Ting., Yan, Shineng., Wei, Liwen., Li, Huiying., Wen, Jiagen., Chen, Guo., Kang, Liqun., Chen, Yuxiang. Determination of 5 bioactive components by TLC and HPLC for quality control of Gankang Granule. Zhongguo xiandai yixue zazhi, 2010, p. 2401-2407.
  4. Lu, Guibao., Lu, Shuhua., Zhang, Guoqing., Xu, Shimei., Li, Deyu., Huang, Qiaoshu. Isolation and identification of flavone-like constituents from Mongolian milkvetch (Astragalus mongholicus). Zhongcaoyao, 1984, p. 452-454.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue